Dehydroepiandrosterone in systemic lupus erythematosus

Rheumatic Disease Clinics of North America

Volumn 26, Issue 2, 2000, Pages 349-362

  Van Vollenhoven, Ronald F ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE;

ACNE; BONE METABOLISM; BONE MINERAL; BONE MINERALIZATION; COGNITION; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034041838     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70142-3     Document Type: Article

References (39)

1. V. Agnello K. Pariser J. Gell Preliminary observations on danazol therapy of systemic lupus erythematosus: Effects on DNA antibodies, thrombocytopenia and complement J Rheumatol 10 1983 682
2. J. Alcocer-Varela D. Alarcon-Segovia Decreased production of and response of interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus J Clin Invest 69 1982 1388
3. B. Araneo T. Dowell B. Woods DHEAS as an effective vaccine adjuvant in elderly humans Ann NY Acad Sci 774 1995 232
4. N.N. Barry J.L. McGuire van Vollenhoven R.F. Dehydroepiandrosterone in systemic lupus erythematosus: Relationship between dosage, serum levels, and clinical response J Rheumatol 25 1998 2352
5. E.A. Belongia C.W. Hedberg G.J. Gleich An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use N Engl J Med 323 1990 357
6. R.A. Daynes B.A. Araneo Natural regulators of T-cell lymphokine production in vivo J Immunother 12 1992 174
7. R.A. Daynes D.J. Dudley B.A. Araneo Regulation of murine lymphokine production in vivo. II Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells Eur J Immunol 20 1990 793
8. R.A. Daynes B.A. Araneo T.A. Dowell Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function J Exp Med 171 1990 979
9. M. Dougados C. Job-Deslandre B. Amor Danazol therapy in systemic lupus erythematosus. A one-year prospective controlled trial on 40 female patients Clinical Trials Journal 24 1987 191
10. P. Ebeling P. Koivisto Physiological importance of dehydroepiandrosterone Lancet 343 1994 1479
11. A. Fam M. Izsak C. Saiphoo SLE and Klinefelter's syndrome Arthritis Rheum 23 1980 124
12. P. Jungers M. Dougados M. Pelissier Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus Arthritis Rheum 25 1982 618
13. P. Jungers K. Nahoul C. Pelissier Low plasma androgens in women with active or quiescent systemic lupus erythematosus Arthritis Rheum 25 1982 454
14. F. Labrie P. Diamond L. Cusan Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women J Clin Endocrinol Metab 82 1997 3498
15. R.G. Lahita Gender and age in lupus Systemic Lupus Erythematosus ed 3 1999 Academic Press San Diego 129
16. R.G. Lahita H.L. Bradlow H.G. Kunkel Alterations of estrogen metabolism in systemic lupus erythematosus Arthritis Rheum 22 1979 1195
17. R.G. Lahita C.Y. Cheng C. Monder Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: Worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women J Rheumatol 19 1992 547
18. R.G. Lahita H.G. Kunkel H.L. Bradlow Increased oxidation of testosterone in systemic lupus erythematosus Arthritis Rheum 26 1983 1517
19. R.G. Lahita H.L. Bradlow E. Ginzler Low plasma androgens in women with systemic lupus erythematosus Arthritis Rheum 30 1987 241
20. M. Linker-Israeli A.C. Bakke R.C. Kitridou Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE) J Immunol 130 1983 2651
21. C. Longcope Metabolism of DHEA Ann NY Acad Sci 774 1995 143
22. J.A. Lucas A.A. Ahmed M.L. Casey Prevention of autoantibody formation and prolonged survival in new Zealand Black/New Zealand White F1 mice fed dehydroisoandrosterone J Clin Invest 75 1985 2091
23. A. Mastunaga B.C. Miller G.L. Cottam Dehydroisoandrosterone prevention of autoimmune disease in NZB/W F1 mice: Lack of an effect on associated immunological abnormalities Biochim Biophys Acta 992 1989 265
24. B. Muller U. Gimsa N.A. Mitchison Modulating the Th1/Th2 balance in inflammatory arthritis Springer Semin Immunopathol 20 1998 181
25. J. Parasrampuria K. Schwartz R. Petesch Quality control of dehydroepiandrosterone dietary supplement products JAMA 280 1998 1565
26. L.N. Parker Control of adrenal androgen secretion Endocrin Metab Clin North Am 20 1991 401
27. M. Petri D. Howard J. Repke Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience Arthritis Rheum 34 1991 1538
28. M. Petri R. Lahita J. McGuire Results of the GL701 (DHEA) multicenter steroid-sparing SLE study Arthritis Rheum 40 suppl 1997 S327
29. J.N.R. Roubinian R. Papoian N. Talal Androgenic hormones modulate autoantibody responses and improve survival in murine lupus J Clin Invest 59 1977 1066
30. T. Suzuki N. Suzuki R.A. Daynes Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T cells Clin Immunol Immunopathol 61 1991 202
31. T. Suzuki N. Suzuki E.G. Engleman Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes from patients with systemic lupus erythematosus (SLE) Clin Exp Immunol 99 1995 251
32. Van Vollenhoven R.F. Dehydroepiandrosterone: Uses and abuses Kelley W.N. Harris E.D. Ruddy S. Textbook of Rheumatology Update Series vol 25 1997 WB Saunders Philadelphia 1
33. Van Vollenhoven R.F. J.L. McGuire Estrogen, progesterone, and testosterone: Can they be used to treat autoimmune diseases? Cleve Clin J Med 61 1994 276
34. Van Vollenhoven R.F. H.O. McDevitt Studies of the treatment of nephritis in NZB/NZW mice with dehydroepiandrosterone [abstract] Arthritis Rheum 35 suppl 1992 S207
35. Van Vollenhoven R.F. E.G. Engleman J.L. McGuire Dehydroepiandrosterone (DHEA) in systemic lupus erythematosus: Results of a double-blinded, placebo-controlled, randomized clinical trial Arthritis Rheum 38 1995 1826
36. Van Vollenhoven R.F. J.L. Park M.C. Genovese A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus Lupus 8 1999 181
37. Van Vollenhoven R.F. L.M. Morabito E.G. Engleman Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months J Rheumatol 25 1998 285
38. O.M. Wolkowitz V.I. Reus E. Roberts Dehydroepiandrosterone (DHEA) treatment of depression Biol Psychiatry 41 1997 311
39. S.S. Yen A.J. Morales O. Khorram Replacement of DHEA in aging men and women Ann NY Acad Sci 774 1995 128